Cimzia (certolizumab pegol) Lyophilized Powder and Solution for Subcutaneous Use

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 WARNINGS AND PRECAUTIONS Risk of Serious Infections Tuberculosis Treatment of latent tuberculosis infection...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts